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Objective: This paper has the purpose to analyze prospectively the treatment results in
patients  with chronic plantar fasciitis resistant to conservative treatment who underwent
extracorporeal  shock wave therapy (ESWT).
Methods: We  evaluated 30 patients (36 feet); 16 (53.3%) patients were  male and 14 (47.7%)
female  with mean age of 48.7 y.o., varying from 33 to 78 y.o.; 16 (53.3%) present the problem
on  the left side, 14 (46.7%) on the right ones and 6 (20%) bilateral; the symptomatology varied
from  6 to 60 months, with the average of 13.58 months. These patients were  submitted to
a  weekly ESWT session for 4 consecutive weeks. We measured the plantar fascia thickness
millimeters  with ultrasound and we applied American Orthopaedic Foot and Ankle Society
(AOFAS)  scale for ankle and hindfoot, and Roles & Maudsley scales in pre ESWT, after one,
three and six months after and decrease in the plantar fascia thickness by the ultrasound
(p  = 0.011) along the different moments studied.
Results: We observed improvement of the evaluated criteria (p < 0.001) and plantar fascia
thickness  by ultrasound (p = 0.011) at different time points studied.
Conclusion: The ESWT can be considered an important tool in the primary or adjuvant treat-
ment  of the chronic plantar fasciitis when associated with conventional therapies. This
methodology  is safe, non-invasive and provides precocious rehabilitation and return to
regular  activities considering the results of the statistical analysis. This resource providesdecrease  in the thickness of the plantar fascia.
©  2013 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda.  
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Tratamento  da  fasciíte  plantar  crônica  pela  terapia  de  ondas  de  choque:
avaliac¸ão  morfológica  ultrassonográﬁca  e  funcional
Palavras-chave:
Fasciíte plantar
Ondas  de choque de alta
energia/uso  terapêutico
Ultrassonograﬁa
Avaliac¸ão
Morfologia
r  e  s  u  m  o
Objetivo: Este trabalho teve como objetivo analisar prospectivamente os resultados do trata-
mento com terapia de ondas de choque (TOC) em pacientes portadores de fasciíte plantar
crônica resistente ao tratamento conservador.
Métodos: Obtivemos 30 pacientes (36 pés), 16 (53,3%) do sexo masculino e 14 (47,7%) do
feminino, cuja idade, em média, foi de 48,37 anos, com variac¸ão  de 33 a 78 anos; 16 (53,3%)
apresentavam a afecc¸ão  no pé esquerdo, 14 (46,7%) no direito e seis (20%) bilateralmente; a
sintomatologia variou de seis a 60 meses, com média de 13,58 meses. Os pacientes foram
submetidos a uma sessão semanal de TOC por quatro semanas consecutivas. Mensuramos
a espessura da fáscia plantar em milímetros pelo ultrassom e usamos a escala da American
Orthopaedic Foot and Ankle Society (AOFAS) para tornozelo e retropé e a escala de Roles
& Maudsley nos momentos pré-TOC, após o primeiro, o terceiro e o sexto meses após a
aplicac¸ão.
Resultados: Observamos melhoria dos critérios avaliados (p < 0,001) e da espessura da fáscia
plantar pelo ultrassom (p = 0,011) nos diferentes momentos estudados.
Conclusão: A TOC pode ser considerada importante instrumento no tratamento primário
ou adjuvante da fasciíte plantar crônica, quando aliada às terapias convencionais. Essa
metodologia é segura, não invasiva e promove reabilitac¸ão  e retorno precoces às ativi-
dades habituais pelos resultados das análises estatísticas. Proporciona também reduc¸ão
da  espessura da fáscia plantar.
© 2013 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
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lantar fasciitis is characterized as a degenerative condition
f  the proximal plantar aponeurosis. The site most frequently
nvolved is at the medial tuberosity of the calcaneus. The
athological ﬁndings from this nosological entity include
egenerative tissue changes characterized by ﬁbroblastic pro-
iferation and presence of inﬂammatory tissue.1–3 It is now
ccepted  that this fasciopathy should be classiﬁed as a type
f  enthesopathy, even though its physiopathology is poorly
nderstood.
Several  therapeutic options have been described, among
hich  conservative treatment is taken to be the preferred
ethod. Satisfactory results have thus been achieved in
round  90% of the patients.
Use  of anti-inﬂammatory medications, analgesics and local
nﬁltration  of corticoids and platelet-rich plasma (PRP) is rec-
mmended.  Furthermore, use of insoles, heel supports, splints
nd  nighttime braces, along with physiotherapy, is also recom-
ended,  with the aim of aiding in achieving remission of the
nﬂammatory  and painful condition.4–6
More  recently, some studies have demonstrated that appli-
ation  of a dehydrated human amniotic membrane (dHAM)
s  effective. Other studies have demonstrated similar efﬁcacy
hrough  application of high molecular weight hyaluronic acid.
hanges to lifestyle habits, such as weight reduction and use
f  appropriate footwear, and also postural changes during
7–10ork, are further recommendations.
The other 10% of the patients, whose condition is not
esolved through conservative treatment, can be considered
o  be cases of recalcitrant fasciopathy. In these cases, surgicalEditora Ltda. 
treatment may  be useful, in order to achieve open or endo-
scopic  release of the plantar fascia,11 with excision of the
diseased tissue. In some speciﬁc cases, simultaneous nerve
decompression is indicated.
In an attempt to avoid an invasive procedure, there have
been  many  studies on shockwave therapy in chronic cases.
This  technique has been shown to be effective for improving
the  symptoms and quality of life of patients with this condi-
tion.  The basic idea of shockwave therapy is to stimulate the
tissue  regeneration process in the bones and tendons.12,13 Its
efﬁcacy  is noted especially in the tissues surrounding the bone
and  tendons, and also at the bone-tendon interface (enthe-
sis).  Release of free radicals, nitric oxide (NO) and substance
P  at the application site, along with inhibition of the enzyme
COX  II, produces an anti-inﬂammatory effect. In experiments
on  tissues subjected previously to shockwave therapy, analy-
sis  under a microscope has demonstrated intensely increased
neovascularization and angiogenesis.
The present study was  conducted with the aim of prospec-
tively  analyzing the results from shockwave treatment on
patients  with recalcitrant fasciopathy, using validated evalu-
ation  methods.
Materials  and  methods
Firstly, a research projected was  designed and submitted for
assessment  by the Scientiﬁc Committee of Hospital IFOR. This
Este é um artigo Open Access sob a licença de CC BY-NC-NDwas duly approved.
This  was  a prospective study in which patients with chronic
plantar  fasciitis that had not responded satisfactorily to con-
servative  therapeutic measures were evaluated. Traditional
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Before
After: 1 month 3 months 6 months
1- Excellent (an excellent result without pain and with complete mobility)
2- Good (a good result with occasional pain)
3- Fair (a fair result with pain after activity)
4- Poor (a poor result with limitation on daily activities)540  r e v b r a s o r t o 
methods such as analgesic and anti-inﬂammatory medica-
tions,  physiotherapy and additional use of braces or insoles
had  been systematically applied.
The inclusion criteria were that the subjects should be
patients  of either sex in whom a diagnosis of plantar fasciitis
had  been made by means of clinical and imaging evaluations,
with  evolution of more  than six months. Individuals with the
following  were  not included: other concomitant conditions of
the  foot and ankle; comorbidities such as diabetes mellitus,
neuropathies or insensitive foot; previous surgery; and non-
acceptance  of participation in the study after having read the
free  and informed consent statement.
Thus, we  built up a group of 30 patients (36 feet), of whom
16  (53.3%) were  male and 14 (47.7%) were  female, with mean
age  of 48.37 years, ranging from 33 to 78 years. With regard
to  laterality, we  observed that 16 patients (53.3%) presented
the  condition on their left foot and 14 (46.7%) on their right
foot,  and that bilaterality occurred in six situations (20%). The
body  mass index (BMI) ranged from 20.89 to 40.60 kg/m2, with
a  mean of 28.48 kg/m2. In our sample, the length of time with
symptoms  ranged from six to 60 months, with a mean of 13.58
months.
We  performed radiographic examinations on the feet, with
weight-bearing, on the side affected by the condition. We
observed  that out of the 30 patients evaluated, 16 (53.3%) pre-
sented  plantar osteophytes in the calcaneus. The mean length
of  these osteophytes was  0.5 cm,  from evaluating the radio-
graphs  on the feet.
The  patients underwent one weekly session of shockwave
therapy for four consecutive weeks. The apparatus used in the
study  was the Swiss Dolorcast®, made by the Swiss company
EMS.  A generator of radial type was  used, and 2000 impulses
were  produced in each session, at a pressure of 0.18 mJ/mm2.
The  application site for this therapy was  the most painful
point  on the foot, which had been indicated by the patient.
For  this application, we developed a diagram composed of four
quadrants (Fig. 1). The odd quadrants (1 and 3) corresponded
to  the proximal and distal medial plantar region and the even
quadrants  (2 and 4) to the proximal and distal lateral plantar
region  of the calcaneus. We observed that 17 patients (56.6%)
indicated  that quadrant number 3 was  the most painful area,
nine  (30%) number 1, four (13.3%) number 2 and one (3.3%)
number  4.
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Fig. 1 – Diagram of the plantar region of the heel, divided
into  quadrants. Quadrant 1, distal medial plantar region;
quadrant 2, distal lateral plantar region; quadrant 3,
proximal  medial plantar region; quadrant 4, proximal
lateral plantar region.Fig. 2 – Roles & Maudsley evaluation.
For evaluating the results after the patients’ treatment, we
used  the scale of the American Orthopaedic Foot and Ankle
Society  (AOFAS) (annex 1) for evaluating the ankle and hind-
foot,  and also the Roles & Maudsley score evaluation method
(Fig.  2). These questionnaires were applied by a professional
who  had not administered the shockwave treatment.
The evaluations on the plantar fascia were  performed by
a  single imaging diagnostics professional, using ultrasonog-
raphy  on the plantar region of the feet. The thickness of this
anatomical  structure was  measured at four times: before the
treatment  and 30, 90 and 180 days after the treatment.
An ultrasound device with a high-frequency transducer
(7–12 MHz) was  used. A transversal measurement in millime-
ters  was  made on the plantar fascia, one centimeter from the
point  of greatest acoustic shadow, which corresponded to the
calcaneal  tubercle. The shockwave therapy was  applied by a
single professional.
The  results obtained were compiled and analyzed statisti-
cally  by a professional who was a specialist in this ﬁeld.
Results
Table 1 demonstrates the descriptive results, which take into
consideration  the side affected by the condition, cases of
bilaterality  and the quadrants in which the shockwaves were
applied.
Table  2 shows the thicknesses of the plantar fascia at the
different  evaluation times and the result from the statistical
analysis. From analysis of variance with repeated measure-
ments,  we  observed that there were  signiﬁcant changes in the
ultrasonographic results (p = 0.011) between the different eval-
uation  times. The examination performed in the ﬁrst month
differed  from the examination in the third month (p = 0.003)
Table 1 – Absolute and relative frequencies of the
variables.
Variable Category n %
Side R  14 48.4
L 16 51.6
Quadrant 1 9 29.0
2 3 12.9
3 17 54.8
4 1 3.2
Bilateral No 24 77.4
Yes 6 19.4
R, right; L, left.
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Table 2 – Descriptive values from ultrasonography.
Time n Mean SD Minimum Maximum
Before 17 0.68 0.36 0.30 2.00
1 month 17 0.64 0.19 0.38 1.10
3 months 17 0.60 0.20 0.33 1.10
6 months 17 0.57 0.18 0.28 0.97
SD, standard deviation.
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Fig. 4 – Graphical representation of the evolution of the
AOFAS  scale.
apy  on conditions of the locomotor system still remains
undeﬁned.
4.00
3.50ltrasonography (USG).
nd sixth month (p = 0.003), with values that were signiﬁcantly
reater than in the other two.
Fig. 3 presents the evolution of the ultrasonographic thick-
ess  at the different times.
Table 3 shows the results from analysis of variance with
epeated measurements, which indicate that there were sig-
iﬁcant changes in the results from the AOFAS scale over
he  course of the evaluations (p < 0.001). The time before the
reatment  presented a signiﬁcant difference in relation to the
ther  times (one month: p < 0.001; three months: p < 0.001; and
ix  months: p < 0.001). The value before shockwave therapy
as  signiﬁcantly lower than the values at the other times.
here  was  a statistically signiﬁcant difference between the
rst  month evaluation and the other times (three months:
 < 0.001; and six months: p < 0.001). In the ﬁrst month, the
esults  were  signiﬁcantly lower than in the third and sixth
onths  of follow-up. The values obtained in the third month
f  evaluation were signiﬁcantly greater than those presented
n  the sixth month of evaluation (p < 0.001).
Fig. 4 shows the results from the AOFAS scale at the differ-
nt  evaluation times.
Table  4 demonstrates the results from the statistical anal-
sis  on the Roles & Maudsley scale, using the Friedman
Table 3 – Descriptive values from AOFAS scale.
Time n Mean SD Minimum Maximum
Before 30 58.87 14.26 36 83
1 month 30 68.20 9.97 44 84
3 months 30 78.23 13.53 44 97
6 months 30 82.83 17.14 36 100
SD, standard deviation.nonparametric test, and it shows that there were  signiﬁcant
changes over the course of the evaluations (p < 0.001). The time
before  shockwave therapy did not present any statistically sig-
niﬁcant difference in relation to the ﬁrst month of evolution
(p  > 0.05). There were differences in the third month (p < 0.05)
and  sixth month (p < 0.05), with signiﬁcantly greater values at
these two times. The results from the ﬁrst month did not differ
from  the other times (three months: p > 0.05; and six months:
p  > 0.05). In addition, the results from the third month did not
differ  from those presented in the sixth month (p > 0.05).
Fig. 5 demonstrates the evolution of the results from the
Roles  & Maudsley scale at the different evaluation times.
Discussion
Use of shockwave therapy has been approved by the Food and
Drug  Administration (FDA), in the United States,14 and by the
National  Sanitary Surveillance Agency (Agência Nacional de
Vigilância Sanitária, ANVISA), in Brazil.
The exact mechanism for the effect of shockwave ther-3.00
2.50
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R
&M
1.50
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Fig. 5 – Graphical representation of the evolution of the
Roles  & Maudsley (R&M) scale.
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Table 4 – Descriptive values from Roles & Maudsley scale.
Time n Mean SD Minimum Maximum P25 Median P75
Before 30 3.28 0.59 2.00 4.00 3.00 3.00 4.00
1 month 30 2.79 0.56 2.00 4.00 2.00 3.00 3.00
3 months 30 2.31 0.76 1.00 3.00 2.00 2.00 3.00
6 months 30 2.14 1.19 1.00 4.00 1.00 2.00 3.50SD, standard deviation.
It is believed that shockwaves promote a biological
response in which several phenomena occur: neovasculariza-
tion,  release of proliferating cell nuclear antigen, endothelial
growth factors, endothelial nitrous oxide15 (blocking of nerve
impulses)  and morphogenetic bone protein. These phenom-
ena  promote increased blood supply and bone and tendon
repair.  Local microtraumas provide stimulation and activa-
tion  of the tissue healing process, which leads to activation of
ﬁbroblast  proliferation and removal of calcareous deposits.16
The efﬁciency of shockwaves has been demonstrated in
a  variety of conditions of the locomotor system. Among
these, pseudarthrosis can be highlighted, with a success rate
of  around 75%. Other indications include: bone necrosis,
tendinosis (calcaneal), insertion enthesopathy, epicondylitis,
bursitis and calcareous tendinitis of the shoulder.17
So far, in preliminary studies, the success rate regarding
pain elimination shown by shockwave therapy has ranged
from  48% to 81%.12
With regard to the beneﬁt provided by shockwave therapy
according to the time elapsed since application, we observed
that  progression of the success rates has been reported, as
follows:  57% after three months,14 48%18 to 83%12 after six
months, 58% after 12 months19 and 77.4% after 24 months.13
These results corroborate the data observed in our study,
although we  only made evaluations until the sixth month after
application.
In the literature, a variety of beneﬁts from using this ther-
apeutic  option have been indicated. Since this method is a
nonoperative  intervention, the potential complications inher-
ent  to surgery cease to exist. The recovery time is signiﬁcantly
shorter and the individual has the possibility of returning to
his  habitual activities on the day after application.20 We also
take  the view that this resource could be used as a last pos-
sibility  before indicating an invasive procedure. Success rates
comparable  with those of surgery and other conventional ther-
apies have been demonstrated for shockwave therapy.8,21
The following are contraindications against applying
shockwave therapy: blood dyscrasia, use of anticoagulants,
presence of tumors, presence of infectious process and chil-
dren  and adolescents when the growth plate is still open.
Regarding the functional aspect of walking, it was  found in
one  study that 51% of the patients who underwent the treat-
ment  were  capable of walking without pain six months later,
in  comparison with individuals who  were  not treated or who
received  placebo. After ﬁve years, 58% of the patients needed
to  undergo surgical release of their plantar fascia, while only
13%  of the group treated with shockwave therapy required this
action.22
In another study in which the authors used the AOFAS scale
to  compare the results between two groups, no statisticallysigniﬁcant differences were found and the patients with
chronic  plantar fasciitis did not demonstrate any signiﬁcant
deﬁcits of range of motion before or after the treatment.23
In our study, when we used the AOFAS scale, we  observed
that  there was  a progressive improvement in the results
between the different evaluation times (76.7%), as shown in
Fig.  5.
Some studies have indicated that the ideal location for
applying shockwaves would be the extremity of the calca-
neus  or the center of the spur of this bone structure, since this
portion  would correspond to the thickest part of the plantar
fascia.  However, others have considered that the ideal location
for  the application would be the point of origin of the pain.24
In evaluating the exact location where the application is
needed,  we  noted that some authors had compared the ther-
apeutic  results between determination of the application site
by means of ﬂuoroscopy and through the patient’s own report.
The  result was  that there was  no signiﬁcant difference in clin-
ical  evolution when different methods were used to identify
the  best location, and the success rates were considered to be
excellent or good, according to the criteria of Roles & Maudsley,
three  months after the application.24
Our results were similar when we used these criteria, with
which  we observed progressive improvement.
From the analysis on our material, we  developed a dia-
gram  consisting of four quadrants, in which the region most
often  indicated as being painful was  the posteromedial region,
which  corresponded to 54.8% of the areas of application. We
consider  that this methodology is reproducible and that it gave
rise  to favorable rates of good results.
Through this, it can be suggested that use of shockwave
therapy should be considered to be a therapeutic option.
Together with shockwave therapy, exercises should be done
at  home in order to stretch the posterior chain. Studies have
demonstrated that the results obtained through concomitant
use  of shockwave therapy and stretching of the posterior chain
are  superior to those done separately.
In another study, magnetic resonance imaging was  used
to  structurally evaluate the plantar fascia thickness among
asymptomatic patients who had previously undergone open
or  endoscopic release of the plantar fascia. The thickness of
this  structure was  two to three times greater than normal,
despite  complete resolution of the perifascial edema and plan-
tar  fasciitis.25
In our study, we  used ultrasonographic measurements
that were systematized to be performed 30, 90 and 180 days
after  applying shockwave therapy. We observed a decrease in
plantar fascia thickness in our patients, compared with the
thickness  before the start of the treatment. This was  inter-
preted  as a reduction in the inﬂammatory process and as
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tretching of the plantar fascia, caused by the malleability and
lasticity  intrinsic to this structure.
Through this resource, we were unable to assess whether
he  heel spur had any inﬂuence on the distribution and
bsorption of shockwaves.
However,  we  emphasize that the high costs of magnetic
esonance imaging may  be diminished through using ultra-
ound.
From  our study, we take the view that shockwave therapy
an  be considered to be an important instrument for primary
r  adjuvant treatment of chronic plantar fasciitis, when allied
ith  conventional therapies. We  consider that this method-
logy  is safe and noninvasive, does not present signiﬁcant
omplications and promotes rehabilitation and an early return
o  habitual activities.
In  a society in which the pace of work is increasing
larmingly, few individuals are able to remain absent from
ork  activities for prolonged periods. In this regard, shock-
ave  therapy was  shown to be an effective resource, through
voiding  the need for a surgical procedure that would leave
hem  off work for a long period. Another important fac-
or  to be considered is that surgical treatment implies high
osts.
onclusion
his study showed that there was  a statistically signiﬁcant
ecrease in the thickness of the plantar fascia in the patients
ho  underwent shockwave therapy (p = 0.011).
According to the AOFAS scale for the hindfoot and
he  Roles & Maudsley scale, the patients in this study
chieved statistically signiﬁcant improvements in their scores
p  < 0.001).
onﬂicts  of  interest
he authors declare no conﬂicts of interest.
ppendix  A.
OFAS scale for clinical evaluation of the ankle and hindfoot
Parameter
1. Pain (40 points)
None  40
Mild, occasional 30
Moderate, every day 20
Severe, almost always present 0
2. Function (50 points)
2.1.  Limitation on activities and need for support
No limitations; no supports 10
No limitations on activities, recreational
limitations; no supports
7
Limitation  on daily and recreational
activities; use of stick
4Signiﬁcant  limitation on daily activities;
use of crutches, walking frame or
wheelchair
0;4 8(6):538–544  543
2.2. Maximum walking distance (in blocks)
More than 6 5
From 4 to 6 4
From 1 to 3 2
Less  than 1 0
2.3. Walking surface
No  difﬁculty on any surface 5
Some difﬁculty on uneven
ground,  stairs or slopes
3
Severe  difﬁculty on uneven
ground,  stairs or slopes
0
2.4.  Gait abnormalities
None  or mild 8
Obvious 4
Severe 0
2.5. Sagittal mobility (ﬂexion + extension)
Normal  or minimal limitation
(30◦ or more)
8
Moderate limitation (15 to 29◦) 4
Severe limitation (less than 15◦) 0
2.6.  Mobility of hindfoot (inversion and eversion)
Normal or mild limitation (75 to
100%)
6
Moderate limitation (25 to 74%) 3
Severe limitation (less than 25%) 0
2.7. Stability of ankle and hindfoot
(anteroposterior + varus-valgus)
Stable 8
Unstable 0
3. Alignment (10 points)
Good  – plantigrade foot with
ankle and hindfoot aligned
10
Fair – plantigrade foot with
some  misalignment and
without  pain
5
Poor  – non-plantigrade foot with
signiﬁcant misalignment and
symptoms
0
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